With a portfolio of essentials and healthcare, P&G focuses on customer acquisition through product innovation. Penetration play is expected to continue at a stable pace, despite the high scope of user additions.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Two factors make Procter and Gamble Hygiene and Healthcare Ltd. an attractive long-term core holding:
Robust growth potential in the Feminine Hygiene segment (65-68% mix of FY24 sales), along with opportunities for market share gains supported by strategic initiatives, including the fortification of significant market advantages, and
Potential for higher margin gains from the long-term trend of premiumization in the Feminine Hygiene segment.
With a portfolio of essentials and healthcare, P&G focuses on customer acquisition through product innovation. Penetration play is expected to continue at a stable pace, despite the high scope of user additions. The stock trades at expensive valuations of 49x/45x FY26E/FY27E P/E.
We do not see any medium-term trigger. We reiterate a Neutral rating at a target price of Rs 15,000 (50x Mar’27E EPS).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Bharat Electronics Q1 Review — Motilal Oswal Maintains 'Buy' On Strong Margin Performance


Kotak Mahindra Bank Is Still A 'Buy' For Motilal Oswal Despite Weak Q1, Revises Target Price — Here's Why


L&T Finance Q1 Results Review — Motilal Oswal Retains 'Buy' Rating Post Healthy Earnings


VA Tech Wabag Gets Motilal Oswal's 'Buy' Initiation Citing Robust Growth Outlook — Check Target Price
